B5-028 GI Cancers, Non-Tubular Flashcards
a tumor in the head of the pancreas is likely to involve the […]
biliary duct
normal pancreas
pancreatic adenocarcinomas arise from
ductal cells
pacreatic NETs arise from
islets of Langerhans
- most common cancer of the pancreas
- third leading cause of cancer deaths
pancreatic ductal adenocarcinoma
risk factors for pancreatic ductal carcinoma
- smoking
- chronic pancreatitis
- diabetes
- BRCA2 and CDKN2A mutations
- older individuals
- back pain, unexplained weight loss, fatigue
- jaundice
- new onset diabetes
pancreatic ductal carcinoma
pancreatic ductal carcinoma in the […] of the pancreas tend to present at a more advanced stage
tail/body
most are in head
mutations seen in pathogenesis of pancreatic ductal carcinoma
early: **KRAS **
later: SMAD4
pancreatic ductal carcinoma
proliferation of malignant glands with or without mucin production
pancreatic ductal carcinoma
fine needle biopsy of pancreatic ductal carcinoma
intital diagnosis by fine needle biopsy
- precursor lesion
- telomere shortening, KRAS mutation (low grade)
- later, CDKN2A mutation (high grade)
pancreatic intraepithelial neoplasia
PanIN
high grade PanIN
2 types of cystic precursor lesions to pancreatic ductal carcinoma
- intraductal papillary mucinous neoplasm
- mucinous cystic neoplasm
always always curable early on
main pancreatic duct dilated and filled with mucin
intraductal papillary mucinous neoplasm
papillary structures lined by mucinous epithelium
intraductal papillary mucinous neoplasm
- majority occur in pancreatic head
- KRAS and GNAS mutations
- more common in men
- can be multifocal
intraductal papillay mucinous neoplasms
mucinous cystic neoplasm
mucinous cystic neoplasm
- more common in females
- occurs in body/tail
- KRAS mutations
- no connection to ductal system
mucinous cystic neoplasm
tumors associated with clinical syndromes caused by abnormal secretion of hormones by the tumor
functional PanNETs
insulinomas, gastrinomas, glucagonomas, somatostatinomas, VIPomas
functional PanNETs
may secrete peptide or biogenic substance at levels insufficient to cause symptoms or do not give rise to a clinical syndrome
non-functional PanNETs
incidentally discovered or become clinically apparent due to size, invasion or metastasis
non-functional PanNETs
tumors not associated with a clinical hormone hypersecretion syndrome
non-functional PanNETs